老年脑肿瘤患者的放射治疗
过去几十年老年人群脑肿瘤发病率上升,其最佳治疗仍存争议,积极放疗可能带来神经毒性和生活质量下降风险。综述指出放化疗联合或挽救性放疗仍为有效选择,立体定向放射外科在脑转移瘤和良性肿瘤中显示生存获益且毒性谱与年轻成人相似,未来需研究最佳放疗技术与剂量分割方案。
要点
- 老年脑肿瘤患者需仔细评估临床状态以指导治疗决策和临床试验设计
- 放化疗联合或挽救性放疗仍与生存获益相关
- 立体定向放射外科用于老年脑转移瘤和良性脑肿瘤有效且毒性谱与年轻成人相似
核心结论
- 老年脑肿瘤患者的最佳管理仍存争议,积极放疗可能伴随高神经毒性风险和生活质量下降。
- 放化疗联合或挽救性放疗仍是与生存获益相关的有效治疗选择。
- 立体定向放射外科在老年脑转移瘤和良性脑肿瘤患者中有效且毒性谱与年轻成人相似。
研究设计与样本
- 综述类文章,检索范围未在摘要中具体报告。
主要发现
- 多项随机研究证实化疗对胶质母细胞瘤或淋巴瘤患者的疗效和安全性。
- 尚无随机试验证明立体定向放射外科在老年脑转移瘤或良性脑肿瘤患者中优于其他放疗技术。
- 近期随机研究和大型回顾性系列数据显示立体定向放射外科与生存优势和与年轻成人相似的毒性谱相关。
临床怎么用
- 对老年脑肿瘤患者应仔细评估临床状态以指导临床决策。
- 可考虑放化疗联合或挽救性放疗作为有效治疗选择。
- 立体定向放射外科可用于老年脑转移瘤和良性脑肿瘤(包括垂体腺瘤、脑膜瘤和听神经瘤)患者。
局限性
- 老年脑肿瘤患者最佳放疗技术和剂量分割方案尚未确定,需未来试验研究临床结局、神经认知功能和生活质量。
- 尚无随机试验证明立体定向放射外科在老年脑转移瘤或良性脑肿瘤患者中优于其他放疗技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The incidence of brain tumors in the elderly population has increased over the last few decades. Current treatment includes surgery, radiotherapy and chemotherapy, but the optimal management of older patients with brain tumors remains a matter of debate, since aggressive radiation treatments in this population may be associated with high risks of neurological toxicity and deterioration of quality of life. For such patients, a careful clinical status assessment is mandatory both for clinical decision making and for designing randomized trials to adequately evaluate the optimal combination of radiotherapy and chemotherapy.Several randomized studies have demonstrated the efficacy and safety of chemotherapy for patients with glioblastoma or lymphoma; however, the use of radiotherapy given in association with chemotherapy or as salvage therapy remains an effective treatment option associated with survival benefit. Stereotactic techniques are increasingly used for the treatment of patients with brain metastases and benign tumors, including pituitary adenomas, meningiomas and acoustic neuromas. Although no randomized trials have proven the superiority of SRS over other radiation techniques in older patients with brain metastases or benign brain tumors, data extracted from recent randomized studies and large retrospective series suggest that SRS is an effective approach in such patients associated with survival advantages and toxicity profile similar to those observed in young adults. Future trials need to investigate the optimal radiation techniques and dose/fractionation schedules in older patients with brain tumors with regard to clinical outcomes, neurocognitive function, and quality of life.
引用
- Minniti G, Filippi AR, Osti MF, et al. Radiation therapy for older patients with brain tumors. Radiat Oncol. 2017. PMID: 28629376. doi:10.1186/s13014-017-0841-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。